Cargando…

Can PCSK7 be A New Pharmaceutical Target?

Detalles Bibliográficos
Autor principal: Kawashiri, Masa-aki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444808/
https://www.ncbi.nlm.nih.gov/pubmed/35034921
http://dx.doi.org/10.5551/jat.ED188
_version_ 1784783314292310016
author Kawashiri, Masa-aki
author_facet Kawashiri, Masa-aki
author_sort Kawashiri, Masa-aki
collection PubMed
description
format Online
Article
Text
id pubmed-9444808
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-94448082022-09-16 Can PCSK7 be A New Pharmaceutical Target? Kawashiri, Masa-aki J Atheroscler Thromb Editorial Japan Atherosclerosis Society 2022-09-01 2022-01-15 /pmc/articles/PMC9444808/ /pubmed/35034921 http://dx.doi.org/10.5551/jat.ED188 Text en 2022 Japan Atherosclerosis Society https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Editorial
Kawashiri, Masa-aki
Can PCSK7 be A New Pharmaceutical Target?
title Can PCSK7 be A New Pharmaceutical Target?
title_full Can PCSK7 be A New Pharmaceutical Target?
title_fullStr Can PCSK7 be A New Pharmaceutical Target?
title_full_unstemmed Can PCSK7 be A New Pharmaceutical Target?
title_short Can PCSK7 be A New Pharmaceutical Target?
title_sort can pcsk7 be a new pharmaceutical target?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444808/
https://www.ncbi.nlm.nih.gov/pubmed/35034921
http://dx.doi.org/10.5551/jat.ED188
work_keys_str_mv AT kawashirimasaaki canpcsk7beanewpharmaceuticaltarget